| Fasiglifam 25 mg BID vs 50 mg QD (NCT01982253) | Takeda | 2013-10-01 |
| Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes (NCT02716610) | Dance Biopharm Inc. | 2013-10-01 |
| Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin (NCT02033876) | Mayo Clinic | 2013-10-01 |
| A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns (NCT03644134) | Rashid Centre for Diabetes and Research | 2013-09-26 |
| Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study (NCT01956305) | Daiichi Sankyo | 2013-09-01 |
| Participatory Design of Patient-centered Depression and Diabetes Care (NCT02178176) | University of Pennsylvania | 2013-09-01 |
| Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes (NCT01940965) | Sanofi | 2013-09-01 |
| Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy (NCT02174146) | Cairo University | 2013-09-01 |
| Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus (NCT02004678) | Daiichi Sankyo | 2013-09-01 |
| Effects of Mixed Herbs on Blood Glucose and Lipid Profile in T2DM Patients (NCT02159846) | International Islamic University Malaysia | 2013-08-01 |
| Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin (NCT01933256) | CureDM | 2013-08-01 |
| IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus (NCT01906294) | IMS HEALTH GmbH & Co. OHG | 2013-08-01 |
| Fatty Acid Regulation of Platelet Function in Diabetes (NCT02373332) | University of Michigan | 2013-08-01 |
| Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes (NCT01918865) | Ionis Pharmaceuticals, Inc. | 2013-08-01 |
| Acute Effect of Phototherapy With Light Emitting Diode (LED) on Muscle and Pulmonary Oxygen Consumption on Diabetes Mellitus (NCT01889784) | Aparecida Maria Catai | 2013-08-01 |
| Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus (NCT01908348) | Boston University | 2013-07-18 |
| A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin (NCT02946541) | Dong-A ST Co., Ltd. | 2013-07-01 |
| Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes (NCT01885260) | Ionis Pharmaceuticals, Inc. | 2013-07-01 |
| Can Whey Protein Improve Glycemic Control in Type 2 Diabetes? (NCT01925248) | University of California, Davis | 2013-07-01 |
| Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects (NCT01941199) | Dong-A Pharmaceutical Co., Ltd. | 2013-07-01 |
| A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus (NCT02040012) | Alizé Pharma | 2013-07-01 |
| Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations (NCT02023489) | Medical University of Vienna | 2013-07-01 |
| Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus (NCT01915849) | Novartis Pharmaceuticals | 2013-07-01 |
| GLP-1 and Hypoglycemia (NCT01858896) | University of Maryland, Baltimore | 2013-07-01 |
| Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients (NCT01823510) | Juan J Badimon | 2013-07-01 |
| An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin (NCT02290301) | LG Life Sciences | 2013-06-28 |
| Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes (NCT01864174) | Bristol-Myers Squibb | 2013-06-20 |
| The Acute Effect of Interval-walking (NCT01987258) | Rigshospitalet, Denmark | 2013-06-01 |
| A Study of LY3025876 in Participants With Diabetes (NCT01870297) | Eli Lilly and Company | 2013-06-01 |
| Triple Therapy in Type 2 Diabetic Patients (NCT01895569) | University of Pavia | 2013-06-01 |
| T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin (NCT01686828) | University of Washington | 2013-06-01 |
| Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study) (NCT02333851) | Hospital Universitario Central de Asturias | 2013-06-01 |
| Effect of Non-surgical Periodontal Treatment on HbA1c in Type 2 Diabetic Patients (NCT02652026) | University of Barcelona | 2013-06-01 |
| Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin (NCT01766778) | Novartis Pharmaceuticals | 2013-05-13 |
| A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002) (NCT02055547) | Merck Sharp & Dohme LLC | 2013-05-10 |
| Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients (NCT01881724) | Chinese University of Hong Kong | 2013-05-01 |
| Correlation Between Plasma- and Endothelial DPP-4 Activity (NCT02192853) | University Hospital, Gentofte, Copenhagen | 2013-05-01 |
| A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria (NCT01847092) | Ardelyx | 2013-05-01 |
| Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study) (NCT01890629) | LG Life Sciences | 2013-05-01 |
| Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes (NCT02949193) | Dong-A ST Co., Ltd. | 2013-05-01 |
| Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus (NCT01865474) | Dexa Medica Group | 2013-05-01 |
| To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately (NCT01535677) | AstraZeneca | 2013-04-01 |
| Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks (NCT01819272) | Elcelyx Therapeutics, Inc. | 2013-04-01 |
| Evaluation of Iphone Technology in Diabetes Treatment (NCT01817595) | Endocrine Research Society | 2013-04-01 |
| A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes. (NCT01843127) | Gilead Sciences | 2013-04-01 |
| Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d (NCT01787396) | LG Life Sciences | 2013-04-01 |
| Short Chain Fatty Acid Metabolism and Energy Metabolism (NCT01826162) | Maastricht University Medical Center | 2013-04-01 |
| Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery (NCT01765270) | Duke University | 2013-03-01 |
| Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus (NCT01406717) | Sun Pharmaceutical Industries Limited | 2013-03-01 |
| Brown Adipose Tissue and Body Mass Index (NCT02173834) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-03-01 |
| Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide (NCT02201550) | Hvidovre University Hospital | 2013-02-01 |
| A Trial Evaluating the Effects of a One-year Lifestyle Intervention in Obese Patients With Type 2 Diabetes (NCT03785379) | University of Padova | 2013-02-01 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024) (NCT01755156) | Merck Sharp & Dohme LLC | 2013-01-11 |
| Comparison of Insulin Mix25 Versus Mix50 (NCT01773473) | Eli Lilly and Company | 2013-01-01 |
| Gut Microbiota in Obesity and Diabetes (NCT02180191) | Gulhane School of Medicine | 2013-01-01 |
| Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8) (NCT01769378) | Eli Lilly and Company | 2013-01-01 |
| Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections (NCT02113332) | Vastra Gotaland Region | 2013-01-01 |
| Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan (NCT01758380) | Novartis Pharmaceuticals | 2013-01-01 |
| A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes (NCT01951235) | Poxel SA | 2013-01-01 |
| A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A (NCT01724814) | Hanmi Pharmaceutical Company Limited | 2012-12-20 |
| A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312) (NCT01702298) | Merck Sharp & Dohme LLC | 2012-12-07 |
| A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011) (NCT01717313) | Merck Sharp & Dohme LLC | 2012-12-05 |
| Diabetes in India Nutrition Guidelines Study (DINGS) (NCT01703611) | Academy of Nutrition and Dietetics | 2012-12-01 |
| Exposure to Type II Diabetes for Two Siblings With the Same Parents (NCT01275235) | Pennington Biomedical Research Center | 2012-12-01 |
| Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM (NCT01804842) | Elcelyx Therapeutics, Inc. | 2012-12-01 |
| Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients (NCT01664676) | University of Aarhus | 2012-12-01 |
| ALA on Glycemic Control in T2DM Participants (NCT02701894) | Unity Health Toronto | 2012-12-01 |
| Enhancing Informal Caregiving to Support Diabetes Self-Management (NCT01684709) | University of Michigan | 2012-12-01 |
| Bone Marrow Derived Stem Cell Transplantation in T2DM (NCT01759823) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2012-12-01 |
| Lifestyle Intervention for Diabetes and Weight Management in Psychosis (NCT01828931) | Centre for Addiction and Mental Health | 2012-12-01 |
| RCT Examining Effects of Probiotics in T2DM Individuals (NCT01752803) | Universiti Kebangsaan Malaysia Medical Centre | 2012-12-01 |
| Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability (NCT01679899) | Centro de Diabetes Curitiba Ltda | 2012-12-01 |
| To Develop a High Quality Health Care Delivery Model for the Management of Hypertension and Diabetes at CHCs and District Hospitals of Himachal Pradesh. (NCT01794052) | Centre for Chronic Disease Control, India | 2012-12-01 |
| A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313) (NCT01709305) | Merck Sharp & Dohme LLC | 2012-11-08 |
| Biomarkers of Diabetic Retinopathy Progression (NCT01607190) | Association for Innovation and Biomedical Research on Light and Image | 2012-11-01 |
| Self-Management Using Smartphone Application for Type2 DM in Real siTuation (SMART-DM) (NCT01820871) | Inje University | 2012-11-01 |
| Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus (NCT01798238) | Handok Inc. | 2012-11-01 |
| Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients (NCT01963663) | Tehran University of Medical Sciences | 2012-11-01 |
| Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020) (NCT01703221) | Merck Sharp & Dohme LLC | 2012-10-24 |
| Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015) (NCT01697592) | Merck Sharp & Dohme LLC | 2012-10-24 |
| Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022) (NCT01704261) | Merck Sharp & Dohme LLC | 2012-10-18 |
| A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266) (NCT01678820) | Merck Sharp & Dohme LLC | 2012-10-10 |
| A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018) (NCT01703208) | Merck Sharp & Dohme LLC | 2012-10-05 |
| A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019) (NCT01698775) | Merck Sharp & Dohme LLC | 2012-10-02 |
| DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients (NCT01588587) | Nagaoka Red Cross Hospital | 2012-10-01 |
| Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin (NCT01703637) | Lin Liao | 2012-10-01 |
| Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes (NCT01647542) | Takeda | 2012-10-01 |
| Nitrate and Exercise-induced Cardiac Troponin T in Type 2 Diabetes (NCT01714674) | Maastricht University Medical Center | 2012-10-01 |
| Effect of Vitamin D Supplementation on Glucose Tolerance in Subjects at Risk for Diabetes With Low Vitamin D. (NCT01726777) | University of Toronto | 2012-10-01 |
| Evaluation of an Intervention Based on Cell Phones (NCT02094846) | Instituto Nacional de Salud Publica, Mexico | 2012-10-01 |
| Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin (NCT01632163) | Sanofi | 2012-10-01 |
| A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years (NCT01681550) | Nagaoka Red Cross Hospital | 2012-10-01 |
| GLP-1 and Non-exercise Activity Thermogenesis in RHZ (NCT01638260) | Maastricht University Medical Center | 2012-10-01 |
| Fatty Acid Radiotracer Comparison Study in Heart Failure Patients (NCT01648296) | Washington University School of Medicine | 2012-09-13 |
| A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016) (NCT01682759) | Merck Sharp & Dohme LLC | 2012-09-10 |
| Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled (NCT01699932) | Sanofi | 2012-09-01 |
| Effects of Obesity Treatments on Food Preferences and Metabolism (NCT01724060) | Imperial College London | 2012-09-01 |
| Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus (NCT01699737) | Akros Pharma Inc. | 2012-09-01 |
| Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia (NCT01818310) | University Hospital Ostrava | 2012-09-01 |
| Lifestyle Therapy for Youth With Type 2 Diabetes (NCT01597154) | University of Manitoba | 2012-09-01 |